Secreted adiponectin as a marker to evaluate in vitro the adipogenic differentiation of human mesenchymal stromal cells

Cytotherapy

Volumn 16, Issue 11, 2014, Pages 1476-1485

  Martella, Elisa ^a,b   Bellotti, Chiara ^a,b   Dozza, Barbara ^a,b   Perrone, Sharon ^a,c   Donati, Davide ^a,b   Lucarelli, Enrico ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c DICKINSON COLLEGE   (United States)

Author keywords

Adipogenesis; Adiponectin; Mesenchymal stromal cells; Quality control

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN; FAT DROPLET; FATTY ACID BINDING PROTEIN 4; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STROMA CELL; MULTIPOTENT STEM CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN SECRETION; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ADIPOCYTE; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; SECRETION (PROCESS);

ADIPOCYTES; ADIPOGENESIS; ADIPONECTIN; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; HUMANS; IN VITRO TECHNIQUES; MESENCHYMAL STROMAL CELLS;

EID: 84912572005     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.05.005     Document Type: Article

References (41)

1. Friedenstein A.J. Precursor cells of mechanocytes. Int Rev Cytol 1976, 47:327-359.
2. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.
3. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
4. Choi J.H., Gimble J.M., Lee K., Marra K.G., Rubin J.P., Yoo J.J., et al. Adipose tissue engineering for soft tissue regeneration. Tissue Eng Part B Rev 2010, 16:413-426.
5. Dimarino A.M., Caplan A.I., Bonfield T.L. Mesenchymal stem cells in tissue repair. Front Immunol 2013, 4:201.
6. Ong W.K., Sugii S. Adipose-derived stem cells: fatty potentials for therapy. Int J Biochem Cell Biol 2013, 45:1083-1086.
7. Jakobsen C., Sorensen J.A., Kassem M., Thygesen T.H. Mesenchymal stem cells in oral reconstructive surgery: a systematic review of the literature. JOral Rehabil 2013, 40:693-706.
8. Labusca L., Mashayekhi K. Adipose-derived stem cells for cartilage regeneration: moving towards clinical applicability. Stem Cell Res Ther 2013, 4:118.
9. Muraglia A., Cancedda R., Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. JCell Sci 2000, 113(Pt 7):1161-1166.
10. Wagner W., Bork S., Horn P., Krunic D., Walenda T., Diehlmann A., et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 2009, 4:e5846.
11. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
12. Fink T., Zachar V. Adipogenic differentiation of human mesenchymal stem cells. Methods Mol Biol 2011, 698:243-251.
13. Rosen E.D., Hsu C.H., Wang X., Sakai S., Freeman M.W., Gonzalez F.J., et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 2002, 16:22-26.
14. Rosen E.D., Walkey C.J., Puigserver P., Spiegelman B.M. Transcriptional regulation of adipogenesis. Genes Dev 2000, 14:1293-1307.
15. Case N., Thomas J., Xie Z., Sen B., Styner M., Rowe D., et al. Mechanical input restrains PPARgamma2 expression and action to preserve mesenchymal stem cell multipotentiality. Bone 2013, 52:454-464.
16. Yu W., Chen Z., Zhang J., Zhang L., Ke H., Huang L., et al. Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells. Mol Cell Biochem 2008, 310:11-18.
17. Donzelli E., Lucchini C., Ballarini E., Scuteri A., Carini F., Tredici G., et al. ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation. JMol Cell Biol 2011, 3:123-131.
18. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005, 26:439-451.
19. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. Anovel serum protein similar to C1q, produced exclusively in adipocytes. JBiol Chem 1995, 270:26746-26749.
20. Zuk P.A. The adipose-derived stem cell: looking back and looking ahead. Mol Biol Cell 2010, 21:1783-1787.
21. Ebinuma H., Miyazaki O., Yago H., Hara K., Yamauchi T., Kadowaki T. Anovel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin Chim Acta 2006, 372:47-53.
22. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. JClin Endocrinol Metab 2001, 86:3815-3819.
23. Matsuo Y., Imanishi T., Kuroi A., Kitabata H., Kubo T., Hayashi Y., et al. Effects of plasma adiponectin levels on the number and function of endothelial progenitor cells in patients with coronary artery disease. Circ J 2007, 71:1376-1382.
24. Schafer A.L., Sellmeyer D.E., Schwartz A.V., Rosen C.J., Vittinghoff E., Palermo L., et al. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). JClin Endocrinol Metab 2011, 96:E1982-E1989.
25. Al-Nbaheen M., Vishnubalaji R., Ali D., Bouslimi A., Al-Jassir F., Megges M., et al. Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Rev 2013, 9:32-43.
26. Chu X., Xu L., Nishimura K., Jisaka M., Nagaya T., Shono F., et al. Suppression of adipogenesis program in cultured preadipocytes transfected stably with cyclooxygenase isoforms. Biochim Biophys Acta 2009, 1791:273-280.
27. Blasi A., Martino C., Balducci L., Saldarelli M., Soleti A., Navone S.E., et al. Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential. Vasc Cell 2011, 3:5.
28. Pierini M., Dozza B., Lucarelli E., Tazzari P.L., Ricci F., Remondini D., et al. Efficient isolation and enrichment of mesenchymal stem cells from bone marrow. Cytotherapy 2012, 14:686-693.
29. de Boer J., Siddappa R., Gaspar C., van Apeldoorn A., Fodde R., van Blitterswijk C. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 2004, 34:818-826.
30. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. JCell Biochem 1997, 64:295-312.
31. Stanford C.M., Jacobson P.A., Eanes E.D., Lembke L.A., Midura R.J. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). JBiol Chem 1995, 270:9420-9428.
32. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006, 7:885-896.
33. Kim S.P., Ha J.M., Yun S.J., Kim E.K., Chung S.W., Hong K.W., et al. Transcriptional activation of peroxisome proliferator-activated receptor-gamma requires activation of both protein kinase A and Akt during adipocyte differentiation. Biochem Biophys Res Commun 2010, 399:55-59.
34. Xia X., Serrero G. Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors. JCell Physiol 1999, 178:9-16.
35. Jaager K., Fatkina A., Velts A., Orav E., Neuman T. Variable expression of lineage regulators in differentiated stromal cells indicates distinct mechanisms of differentiation towards common cell fate. Gene 2014, 533:173-179.
36. Pevsner-Fischer M., Levin S., Zipori D. The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev 2011, 7:560-568.
37. Digirolamo C.M., Stokes D., Colter D., Phinney D.G., Class R., Prockop D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999, 107:275-281.
38. Russell K.C., Phinney D.G., Lacey M.R., Barrilleaux B.L., Meyertholen K.E., O'Connor K.C. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 2010, 28:788-798.
39. Lo Surdo J., Bauer S.R. Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells. Tissue Eng Part C Methods 2012, 18:877-889.
40. Lo Surdo J.L., Millis B.A., Bauer S.R. Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells. Cytotherapy 2013, 15:1527-1540.
41. Aldridge A., Kouroupis D., Churchman S., English A., Ingham E., Jones E. Assay validation for the assessment of adipogenesis of multipotential stromal cells: a direct comparison of four different methods. Cytotherapy 2013, 15:89-101.